Literature DB >> 23572273

Efficacy of liver assisting in patients with hepatic encephalopathy with special focus on plasma exchange.

Poul Stenbøg1, Troels Busk, Fin Stolze Larsen.   

Abstract

Severe liver injury result in development of hepatic encephalopathy (HE) and often also in brain edema that is a potentially fatal complication. HE and brain edema are correlated to the level and persistence of hyperammonemia and the presence of systemic inflammation. Treatment of HE and brain edema is based on restoring and keeping normal physiological variables including tonicity, blood gasses, lactate, temperature and vascular resistance by a wide variety of interventions. In addition liver support devices improve the stage of HE, cerebral metabolic rate for oxygen and glucose, and are used either as a bridge to liver transplantation or liver recovery in patients with fulminant hepatic failure and in patients with acute-on-chronic liver failure. This short review will mainly focus on the management and efficacy of doing plasma exchange on HE in patients with acute HE.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23572273     DOI: 10.1007/s11011-013-9403-5

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  18 in total

1.  Value of plasmapheresis in hepatic encephalopathy.

Authors:  J J Riviello; G E Halligan; S P Dunn; S J Widzer; C M Foley; G N Breningstall; W D Grover
Journal:  Pediatr Neurol       Date:  1990 Nov-Dec       Impact factor: 3.372

2.  Cerebral blood flow, oxygen metabolism and transcranial Doppler sonography during high-volume plasmapheresis in fulminant hepatic failure.

Authors:  F S Larsen; B A Hansen; E Ejlersen; N H Secher; J O Clemmesen; N Tygstrup; G M Knudsen
Journal:  Eur J Gastroenterol Hepatol       Date:  1996-03       Impact factor: 2.566

3.  Effect of plasma exchange on serum tissue inhibitor of metalloproteinase 1 and cytokine concentrations in patients with fulminant hepatitis.

Authors:  T Nakamura; C Ushiyama; S Suzuki; N Shimada; I Ebihara; M Suzaki; T Takahashi; H Koide
Journal:  Blood Purif       Date:  2000       Impact factor: 2.614

4.  Plasmapheresis with plasma exchange in hepatic coma. II. Fulminant viral hepatitis as a systemic disease.

Authors:  M J Lepore; L J Stutman; C A Bonanno; E F Conklin; J G Robilotti; P J McKenna
Journal:  Arch Intern Med       Date:  1972-06

5.  Plasmapheresis in hepatic coma.

Authors:  L Demeulenaere; F Barbier; P Vermeire
Journal:  Lancet       Date:  1969-01-18       Impact factor: 79.321

6.  Effect of supportive extracorporeal treatment in liver transplantation recipients and advanced liver failure patients.

Authors:  Fatma N Ozdemir; Emre Tutal; Siren Sezer; Gürden Gür; Ayse Bilgic; Mehmet Haberal
Journal:  Hemodial Int       Date:  2006-10       Impact factor: 1.812

7.  Usefulness of artificial liver support for pretransplant patients with fulminant hepatic failure.

Authors:  H Sekido; K Matsuo; K Takeda; M Ueda; D Morioka; T Kubota; K Tanaka; I Endo; S Togo; H Shimada
Journal:  Transplant Proc       Date:  2004-10       Impact factor: 1.066

8.  Plasmapheresis in acute liver failure.

Authors:  J G Freeman; K Matthewson; C O Record
Journal:  Int J Artif Organs       Date:  1986-11       Impact factor: 1.595

9.  High volume plasma exchange in fulminant hepatic failure.

Authors:  J Kondrup; T Almdal; H Vilstrup; N Tygstrup
Journal:  Int J Artif Organs       Date:  1992-11       Impact factor: 1.595

10.  Treatment of acute liver failure with hemodetoxification techniques.

Authors:  G Splendiani; M Tancredi; M Daniele; U Giammaria
Journal:  Int J Artif Organs       Date:  1990-06       Impact factor: 1.595

View more
  7 in total

Review 1.  Current state of knowledge of hepatic encephalopathy (part IV): Management of Hepatic Encephalopathy by liver support systems.

Authors:  Tarek Hassanein
Journal:  Metab Brain Dis       Date:  2016-12-24       Impact factor: 3.584

2.  Liver dialysis in acute-on-chronic liver failure: current and future perspectives.

Authors:  Rakhi Maiwall; Jaswinder Singh Maras; Suman Lata Nayak; Shiv Kumar Sarin
Journal:  Hepatol Int       Date:  2014-04-24       Impact factor: 6.047

Review 3.  Clinical science workshop: targeting the gut-liver-brain axis.

Authors:  Vishal C Patel; Helen White; Sidsel Støy; Jasmohan S Bajaj; Debbie L Shawcross
Journal:  Metab Brain Dis       Date:  2015-10-08       Impact factor: 3.584

4.  Continuous molecular adsorbent recirculating system treatment in 69 patients listed for liver transplantation.

Authors:  Per Olin; John Hausken; Aksel Foss; Tom Hemming Karlsen; Espen Melum; Håkon Haugaa
Journal:  Scand J Gastroenterol       Date:  2015-04-11       Impact factor: 2.423

5.  Artificial liver support system improves short- and long-term outcomes of patients with HBV-associated acute-on-chronic liver failure: a single-center experience.

Authors:  Gang Qin; Jian-Guo Shao; Bin Wang; Yi Shen; Jian Zheng; Xian-Jin Liu; You-Yi Zhang; Yan-Mei Liu; Yan Qin; Lu-Jun Wang
Journal:  Medicine (Baltimore)       Date:  2014-12       Impact factor: 1.889

6.  A prognostic model for hepatitis B acute-on-chronic liver failure patients treated using a plasma exchange-centered liver support system.

Authors:  Zhongyang Xie; Laurencia Violetta; Ermei Chen; Kaizhou Huang; Daxian Wu; Xiaowei Xu; Xiaoxi Ouyang; Yalei Zhao; Lanjuan Li
Journal:  J Clin Apher       Date:  2019-11-26       Impact factor: 2.821

7.  Therapeutic Plasma Exchange with Continuous Renal Replacement Therapy for Pediatric Acute Liver Failure: A Case Series from Thailand.

Authors:  Sirawut Trepatchayakorn; Nataruks Chaijitraruch; Voranush Chongsrisawat; Ankanee Chanakul; Lalida Kongkiattikul; Rujipat Samransamruajkit
Journal:  Indian J Crit Care Med       Date:  2021-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.